View of 5-years Follow-up after Primary Prevention of Cardiovascular Events with Aspirin in Patients with Type II Diabetes Mellitus

Return to Article Details 5-years Follow-up after Primary Prevention of Cardiovascular Events with Aspirin in Patients with Type II Diabetes Mellitus Download Download PDF